Skin & Formulation,6th Symposium – Committee and Programme

Chairs of the conference 
  • Prof. Vincent Faivre, Paris-Saclay University
  • Dr Anne-Marie Pensé-Lhéritier (HDR), President of FRMGalesens
Programme Committee
  • Dr Frédéric Bonté, Director of Scientific Communication, Guerlain
  • Prof. Laurence Coiffard, University of Nantes
  • Prof. Vincent Faivre, Paris-Saclay Universirty
  • Prof. Nicolas Huang, Paris-Saclay University
  • Dr Valérie Muguet, Project Manager, Galenic Formulation, Laboratoires Pierre Fabre, Division Medical Care
  • Dr Anne-Marie Pensé-Lhéritier (HDR), President of FRMGalesens

Monday 2nd October 2023

Tuesday 3rd October 2023

8:00-9:00Registration 8:15-8:45Opening door
9:00-9:15Welcome speech STRATEGIES OF PRESERVATION
9:15-10:00OPENING LECTURE 8:45-9:20Dr Joana Marques Marto: Waterless formulation in skin research
 Prof. Marc Brown: Risk mitigation in Topical Product Development: Orthodoxy, Automation and Innovation 9:20-9:55       Invited speaker: Preservatives and microbiotes   
 SKIN BIOLOGY AND PATHOLOGIES 9:55-10:15Selected speaker
10:00-10:35Prof. Laurent Misery: Sensitive skins: diagnosis and management 10:15-   10:45Coffee break and poster session
10:35-10:55Selected speaker 10:45-   11:20   Dr Pascale Gauthier: Formulation without preservatives: packaging
10:55-11:25Coffee break and poster session 11:20-   11:40Selected speaker
11:25-12:00   Dr Georgios Stamatas: Recent advances in skin maturation during infancy and childhood 11:40-   12:00Selected speaker
12:00-12:20Selected speaker 12:00-   12:20Selected speaker
12:20-12:40Selected speaker 12:20-   13:30Lunch break and poster session
12:40-14:00Lunch break and poster session NEW DIRECTIONS IN SKIN DELIVERY: TECHNOLOGIES
 NEW DIRECTIONS IN SKIN DELIVERY: FORMULATION 13:30-   14:05   Invited speaker: 3D printed products and skin repair – title tbc
14:00-14:35    Invited speaker: “Controversial” excipients: myths and facts  (title tbc) 14:05-   14:40   Prof. Ryan Donnelly: Micro-needles and skin applications, new developments


Xavier Ormancey: “Controversial” excipients: strategy on substitution depending on regulatory status 14:40-   15:00Selected speaker
15:10-15:30Selected speaker 15:00-   15:35Dr Franciska Erdö: Raman spectroscopy in skin research – some practicle examples
15:30-16:00Coffee break and poster session 15:35-   15:55Selected speaker
16:00-16:45    Dr Emilie Munnier & Dr François-Xavier Legrand: Deep eutetic solvents for skin formulations  15:55-   16:15Selected speaker
16:45-17:05Invited speaker 16:15-   16:30Conclusion
17:05-17:25Selected speaker  

Prof. Marc Brown BSc PhD, CChem FRSC, Professor

Prof. Marc Brown co-founded MedPharm in August 1999  and he  has been the guiding force behind MedPharm’s scientific developments and intellectual property since its inception. He currently acts as Board Director and Chair of MedPharm’s Scientific Advisory Committee.  Prior to MedPharm he was an academic in the Pharmacy Departments at King’s College London (KCL) and the University of Hertfordshire. He retains honorary and visiting Professorships at the University of Reading, KCL, and De Montford University and in 2022 was awarded the status of Professor Emeritus of the University of Hertfordshire. He has over 200 publications and 26 patents describing his work. His research interests lie mainly in drug delivery to the skin, nail and airways and to date, he has been involved in the pharmaceutical development of over 55 products that are now on the market in Europe, America and Japan.

Franciska Erdő, PhD
Faculty of Information Technology and Bionics
Pázmány Péter Catholic University

Dr. Franciska Erdő has a PhD degree in pharmacy and pharmacology. She was working for research institutes in Germany (Max Planck Institute for Neurological Research, Cologne and Charité University, Berlin) and in Hungary (BIOREX Ltd, Veszprém and IVAX Drug Research Institute, Budapest) for several years. She has experience also from pharmaceutical industry (Sanofi-Synthelabo-Chinoin and SOLVO Biotechnology). Her previous projects focussed on the analysis of pathophysiology of stroke, blood-brain barrier and development new therapeutic strategies. Since 2014 she has been working for Pázmány Péter Chatholic University, Budapest as an associate professor and as a labhead. She moved to dermatology and cosmeto-scientific research fields. Her main expertise is drug delivery across the physiological barriers (dermal barrier, nasal barrier, blood-brain barrier etc.). Currently she is involved in a collaborative research on skin analysis and RAMAN spectroscopy with University of Tours, France. Also she is the supervisor of PhD, MSc and BSc students. She is the author of more than 70 scientific papers and several book chapters and editor of books.

Dr Pascale Gauthier, Pharmacist, PhD, Charge of courses,  Auvergne University

Pascale Gauthier is a Pharmacist (D. Pharm.) with a research background: Biopharmaceutical Master (DEU) ‘New gelling process for oils, study of manufacture of sun care oleogels’, specific Master in Pharmacokinetic (DEA) Pharmacokinetic study of antihypertensive drug and its metabolites after single and repeated dose’ and PhD ‘Rotogranulation process used for manufacture of spheres.’  She was involved in several patents, international publications, conferences, Thesis and is judging for Pharmapack Awards (Exhibitors and Health products categories), CPhI (Excellence in Pharma various) and Design French Institute (Janus). Her researches focus on modified release forms, pharmaceutical design and categories of users, digital in health and beauty areas as well as innovative packaging and formulations for drug forms and cosmetics.

Dr Joana Marques Marto, PhD, Assistant Professord at Faculty of Pharmacy, University of Lisbon

Joana Marques Marto is currently an Assistant Professor at Faculty of Pharmacy, University of Lisbon. Since the beginning of her career, Joana Marto’s main research interests have been the development and characterization of drug delivery systems for topical application. Further, she always focused on transposing the fundamental research to the applied (market).

Prof. Laurent Misery, University of Brest

Professor of dermatology at the university of Brest, head of the department of dermatology of the university hospital of Brest, director of the french expert centre on pruritus, director of the laboratory interactions neurons-keratinocytes (LINK), chair holder of the partnership chair of neuro-sensory dermatology, author of more than 50 referenced papers on sensitive skin

Xavier Ormancey, MSc, Laboratoires Pierre Fabre

Mr. Xavier Ormancey, MSc, is the Director of Research and Development for Pierre Fabre Dermo-Cosmetics and Personal Care. He has more than 35 years experience in the beauty industry in France and in USA (L’Oréal, Chanel, Yves Rocher, Beautycounter). As a specialist of natural cosmetics and clean beauty, he initiated the Conscious Care inception at Pierre Fabre, which enables the formulation of a new generation of dermo-cosmetic products safer and more efficient but also more committed and more respectful of resources and people.

Georgios Stamatas, PhD, Research Associate Director &Fellow, Translational Science, Johnson & Johnson Consumer Health

Dr Georgios Stamatas is a Biomedical Engineer with more than 20 years of international experience in Health Care industry. He is passionate about discovering actionable scientific insights, currently focusing on the understanding of skin physiology and the effects of topical skin care products. He is leading a scientific team pioneering work that ranges from microbiome and metabolome to computational biology and development on non-invasive clinical methods. This research has led to an important number of global “firsts” supporting the scientific credentials of Johnson & Johnson Consumer Health, including a paradigm shift in our knowledge of infant skin maturation and understanding the mechanisms of cutaneous adverse reactions during oncology therapy. Dr. Stamatas holds a PhD in Chemical/Biomedical Engineering and has co-authored more than 100 peer-review publications and 14 patents.